Collegium Pharmaceutical, Inc.
NASDAQ: COLL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Vikram Karnani
- Employees
- 357
- Headquarters
- Stoughton, United States
- IPO year
- 2015
- Market cap
- $1.2B
- Website
- https://www.collegiumpharma.com
Loading COLL…
Loading profile data…Frequently asked questions about COLL
What does Collegium Pharmaceutical, Inc. (COLL) do?
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, sp...
Where does COLL trade?
Collegium Pharmaceutical, Inc. (COLL) trades on the NASDAQ Global Select.
What sector is COLL in?
Collegium Pharmaceutical, Inc. (COLL) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Collegium Pharmaceutical, Inc.?
Vikram Karnani is the chief executive officer of Collegium Pharmaceutical, Inc. (COLL).
Where is Collegium Pharmaceutical, Inc. headquartered?
Collegium Pharmaceutical, Inc. is headquartered in United States.
Does COLL pay a dividend?
Collegium Pharmaceutical, Inc. (COLL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COLL go public?
Collegium Pharmaceutical, Inc. (COLL) completed its initial public offering in 2015.